Biogen will release data from clinical trials for a few of its investigational treatments over the next few months, which should boost its shares, per JPMorgan.
If you purchase through our Amazon affiliate links, we may receive a small compensation!
26 words
1–2 minutes
Biogen is set for big gains on slate of trial data releases, JPMorgan says
AMAZON TODAY’S DEALS